United Kingdom· GB-APID-40383311000001100
Sotrovimab 500mg/8ml solution for infusion vials
A sotrovimab product containing sotrovimab, registered in United Kingdom by GlaxoSmithKline UK Ltd. The same ATC class is registered in 7 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Sotrovimab is registered in 7 of 19 countries.
Countries holding a registration under ATC J06BD05 (sotrovimab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Sotrovimab · ATC J06BD05
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Polandprice
- Spainprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sotrovimab
- Manufacturer
- GlaxoSmithKline UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- J06BD05
- ATC class
- Sotrovimab
- Defined daily dose
- 0.5 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sotrovimab in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumXevudy 500 mgGlaxoSmithKline Trading Services
- DenmarkXevudyGlaxoSmithKline Trading Services Limited
- SpainXEVUDY 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONGlaxosmithkline Trading Services Limited
- FinlandXevudyGlaxoSmithKline Trading Services Limited
- FranceXEVUDY 500 mg, solution à diluer pour perfusionGLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- PolandXevudyGlaxoSmithKline Trading Services Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9780506-80ce-4e6f-88be-7a49a58e6a76 GET /v1/drugs/d9780506-80ce-4e6f-88be-7a49a58e6a76?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40383311000001100",
"desc": "Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd)",
"form": "Solution for infusion",
"vpid": "40227411000001101",
"source": "dmd",
"vtm_id": "1162694008",
"strength": "62.5 mg",
"substance": "Sotrovimab",
"ingredient": "Sotrovimab",
"supplier_code": "4012301000001105"
}See everything about sotrovimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.